CLINICAL_TRIALS
trial_result
· 2015-08-26
Clinical Trial Update: Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML [Phase 3]
Summary
Phase 3 study of BMS-354825 (nilotinib) in chronic-phase chronic myelogenous leukemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Myeloid Leukemia, Chronic, Chronic-Phase | Phase 3 | Status: COMPLETED | Results posted: 2015-08-26